首页> 外文期刊>Pediatric rheumatology online journal >Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature
【24h】

Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature

机译:霉酚酸酯成功治疗小儿IgG4相关系统性疾病:病例报告和小儿自身免疫性胰腺炎文献复习

获取原文
           

摘要

Autoimmune pancreatitis is frequently associated with elevated serum and tissue IgG4 levels in the adult population, but there are few reports of pediatric autoimmune pancreatitis, and even fewer reports of IgG4 related systemic disease in a pediatric population. The standard of care treatment in adults is systemic corticosteroids with resolution of symptoms in most cases; however, multiple courses of corticosteroids are occasionally required and some patients require long term corticosteroids. In these instances, steroid sparing disease modify treatments are in demand. We describe a 13-year-old girl with IgG4 related systemic disease who presented with chronic recurrent autoimmune pancreatitis resulting in surgical intervention for obstructive hyperbilirubinemia and chronic corticosteroid treatment. In addition, she developed fibrosing medianstinitis as part of her IgG4 related systemic disease. She was eventually successfully treated with mycophenolate mofetil allowing for discontinuation of corticosteroids. This is the first reported use of mycophenolate mofetil for IgG4 related pancreatitis. Although autoimmune pancreatitis as part of IgG4 related systemic disease is rarely reported in pediatrics, autoimmune pancreatitis is also characterized as idiopathic fibrosing pancreatitis. All pediatric autoimmune pancreatitis cases reported in the world medical literature were identified via a PUBMED search and are reviewed herein. Twelve reports of pediatric autoimmune pancreatitis were identified, most of which were treated with corticosteroids or surgical approaches. Most case reports failed to report IgG4 levels, so it remains unclear how commonly IgG4 related autoimmune pancreatitis occurs during childhood. Increased evaluation of IgG4 levels in patients with autoimmune pancreatitis may shed further light on the association of IgG4 with pancreatitis and the underlying pathophysiology.
机译:自身免疫性胰腺炎通常与成人人群的血清和组织IgG4水平升高有关,但是,儿科自身免疫性胰腺炎的报道很少,而儿科人群中与IgG4相关的全身性疾病的报道则更少。成人的护理标准是全身性皮质类固醇激素,大多数情况下症状可缓解。但是,偶尔需要多疗程的皮质类固醇激素治疗,有些患者需要长期服用皮质类固醇激素。在这些情况下,需要减少类固醇疾病的治疗。我们描述了一名患有IgG4相关系统疾病的13岁女孩,她患有慢性复发性自身免疫性胰腺炎,导致手术治疗阻塞性高胆红素血症和慢性皮质类固醇治疗。此外,她还患有纤维化性纵隔炎,这是与IgG4相关的全身性疾病的一部分。最终她成功地接受了霉酚酸酯治疗,允许停用皮质类固醇激素。这是霉酚酸酯对IgG4相关性胰腺炎的首次报道。尽管在儿科患者中很少报道自身免疫性胰腺炎是IgG4相关系统性疾病的一部分,但自身免疫性胰腺炎也被称为特发性纤维化胰腺炎。通过PUBMED搜索确定了世界医学文献中报告的所有小儿自身免疫性胰腺炎病例,并在此进行了综述。鉴定出十二篇小儿自身免疫性胰腺炎的报告,其中大多数用皮质类固醇或手术方法治疗。大多数病例报告未能报告IgG4水平,因此尚不清楚IgG4相关的自身免疫性胰腺炎在儿童期的发生频率。自身免疫性胰腺炎患者对IgG4水平的更高评价可能会进一步阐明IgG4与胰腺炎的关联以及潜在的病理生理学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号